Newsroom
  • Location:Home
  • Newsroom

Partnership Opportunities

  • Date: 2017-10-17
  • Pageview: 44495

Sinovac has established a dedicated international business development team and an international regulatory team since 2007 looking for long-term partnership outside of China. Our team has the experience of working with partners through a wide spectrum of transactions from in-licensing, technology transfer, to product export. We offer flexibility and creativity during the project planning. Our current partners include established pharmaceutical companies, small biotech companies, local distributors, and academia (including graduate and post-doctoral research programmes). Sinovac have strong R&D capability to provide high-quality product, and believe external collaboration is as important as internal development. We believe that by working together with you we can contribute more to global health care improvement, and to impact the lives of millions.

Currently Sinovac has launched Inactivated Hepatitis A vaccine, Inactivated EV71 vaccine, Seasonal Influenza vaccine, Pandemic Influenza vaccine, H1N1 vaccine, and Mumps vaccine. Sinovac is expecting to launch its pipeline products in next few years, including 23-Valent Pneumococcal Polysaccharide vaccine, Sabin Inactivated Polio vaccine and Varicella vaccine etc. (Please refer to “R&D Pipeline” for prospective distribution.)

With years of experience in global market, we would like to provide our long-term partner with best products, services, technical support, especially our characterized marketing and sales policies.

Contact us

If you are interested in working with us or would like more information, please email us at info@sinovac.com.

Bookmark and Share

Copyright © 2001-2015 Sinovac Biotech Ltd. All Rights Reserved.

Add: No. 39 Shangdi Xi Road, Haidian District, Beijing, P.R.C. 100085 Supported by elongtian